Quinapril And Hydrochlorothiazide 20/12.5 Tablet
NDC Package 69097-829-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Quinapril And Hydrochlorothiazide 20/12.5 tablets is quinapril and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to quinapril or hydrochlorothiazide and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. This formulation utilizes a tablet delivery system. Marketed by Cipla Usa Inc., this product is identified by NDC 69097-829 and is authorized under FDA application ANDA201356.

Identification & Billing

NDC Package Code
69097-829-05
Package Description
90 TABLET in 1 BOTTLE
Product Code
69097-829
11-Digit Billing Format
69097082905
RxNorm Crosswalk
  • RxCUI: 310796 - quinapril 10 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet
  • RxCUI: 310796 - hydrochlorothiazide 12.5 MG / quinapril 10 MG Oral Tablet
  • RxCUI: 310796 - HCTZ 12.5 MG / quinapril (as quinapril hydrochloride) 10 MG Oral Tablet
  • RxCUI: 310796 - HCTZ 12.5 MG / quinapril 10 MG Oral Tablet
  • RxCUI: 310797 - quinapril 20 MG / hydroCHLOROthiazide 12.5 MG Oral Tablet

Clinical Specifications

Proprietary Name
Quinapril And Hydrochlorothiazide 20/12.5
Non-Proprietary Name
Quinapril And Hydrochlorothiazide 20/12.5
Substance Name
Hydrochlorothiazide; Quinapril Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Quinapril and hydrochlorothiazide tablets are contraindicated in patients who are hypersensitive to quinapril or hydrochlorothiazide and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Because of the hydrochlorothiazide components, this product is contraindicated in patients with anuria or hypersensitivity to other sulfonamide-derived drugs. Do not co-administer quinapril and hydrochlorothiazide with aliskiren: in patients with diabetes.

Regulatory & Marketing

Labeler Name
Cipla Usa Inc.
Product Type
Human Prescription Drug
FDA Application #
ANDA201356
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
07-20-2016
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69097-829-05 identifies a specific commercial package of 90 tablet in 1 bottle of Quinapril And Hydrochlorothiazide 20/12.5, a human prescription drug labeled by Cipla Usa Inc.. This tablet is formulated for oral use and contains hydrochlorothiazide; quinapril hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Cipla Usa Inc. on July 20, 2016. The current certification is valid through December 31, 2026.

How is this Cipla Usa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69097082905. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69097-829-05
11-Digit CMS (5-4-2)
69097-0829-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.